Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of bacteremia and is associated with significant morbidity and mortality. Prior studies evaluating the association of vancomycin MICs with clinical outcomes in patients with MRSA bacteremia have been inconsistent. This study evalu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Adani, Shaili, Bhowmick, Tanaya, Weinstein, Melvin P., Narayanan, Navaneeth
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2018
Teme:
Clinical Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913979/
https://ncbi.nlm.nih.gov/pubmed/29378704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02512-17
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki